Changes in bone mineral content after surgical treatment of morbid obesity

Metabolism: Clinical and Experimental

Volumn 53, Issue 7, 2004, Pages 918-921

  Von Mach, M A ^b   Stoeckli, R ^b   Bilz, S ^b   Kraenzlin, M ^b   Langer, I ^b   Keller, U ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; SILICONE;

ABSORPTIOMETRY; ADULT; ARTICLE; BODY MASS; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MORBID OBESITY; MORBIDITY; OSSIFICATION; OSTEOLYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SERUM; STOMACH BYPASS; X RAY ANALYSIS;

AMINO ACIDS; ANASTOMOSIS, ROUX-EN-Y; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; CONSTRICTION; DENSITOMETRY, X-RAY; FEMALE; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; OSTEOCALCIN; STOMACH;

EID: 3042572544     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.01.015     Document Type: Article

References (41)

1. Kuczmarski R.J., Flegal K.M., Campbell S.M., et al. Increasing prevalence of overweight among US adults. The national health and nutrition examination surveys, 1960 to 1990. JAMA. 272:1994;205-211
2. Sjostrom C.D., Lissner L., Wedel H., et al. Reduction in incidence of diabetes, hypertension and lipid disturbance after intentional weight loss induced by bariatric surgery The SOS intervention study. Obes Res. 7:1999;477-484
3. Fried M., Peskova M., Kasalicky M. Bariatric surgery in some "central and east-European (formerly Eastern block)" countries - Current status and prediction for the next millennium. Obes Surg. 10:2000;255-258
4. Abraham S., Johnson C.L. Prevalence of severe obesity in adults in the United States. Am J Clin Nutr. 33:1980;364-369
5. Seidell J.C. Obesity in Europe. Obes Res. 3:1995;89-93
6. von Mach M.A., Keller U. Komorbiditäten und Beschwerden bei Übergewicht und bei morbider Adipositas. Schweiz Rundsch Med Prax. 90:2001;1569-1574
7. Narbro K., Agren G., Jonsson E., et al. Comparison with a selected population sample and long-term changes after conventional and surgical treatment The SOS intervention study. Arch Intern Med. 162:2002;2061-2069
8. Deitel M., Shikora S.A. The development of the surgical treatment of morbid obesity. J Am Coll Clin Nutr. 21:2002;365-371
9. Martin L.F., Hunter S.M., Lauve R.M., et al. Severe obesity Expensive to society, frustrating to treat, but important to confront. South Med J. 88:1995;895-902
10. Stunkard A.J. Current views of obesity. Am J Med. 100:1996;230-236
11. Brolin R.E. Update: NIH consensus conference: Gastrointestinal surgery for severe obesity. Nutrition. 13:1996;403-404
12. Kolanowski J. Surgical treatment for morbid obesity. Br Med Bull. 53:1997;433-444
13. "laparoscopic gastric banding" bei 130 konsekutiven Patienten. Schweiz Med Wochenschr. 128:1998;1239-1246
14. Doherty C., Maher J.W., Heitshusen D.S. Long-term data indicate a progressive loss in efficacy of adjustable silicone gastric banding for the surgical treatment of morbid obesity. Surgery. 132:2002;724-728
15. Barrow C.J. Roux-en-Y gastric bypass for morbid obesity. AORN J. 76:2002;593-604
16. Msika S. La chirurgie de l'obésité morbide de l'adulte 1. Efficacité clinique des différents procédés chirurgicaux. J Chir (Paris). 139:2002;94-204
17. Belachew M., Legrand M.J., Vincent V. History of Lap-Band From dream to reality. Obes Surg. 11:2001;297-302
18. Liedman B., Bosaeus I., Mellstrom D., et al. Osteoporosis after total gastrectomy. Results of a prospective, clinical study. Scand J Gastroenterol. 32:1997;1090-1095
19. Bano G., Rodin D.A., Pazianas M., et al. Reduced bone mineral density after surgical treatment for obesity. Int J Obes Relat Metab Disord. 23:1999;361-365
20. Buffington C., Walker B., Cowan G.S. Jr, et al. Vitamin D deficiency in the morbidly obese. Obes Surg. 3:1993;421-424
21. Tothill P., Hannan W.J., Wilkinson S. Comparison between a pencil beam and two fan beam dual energy x-ray absorptiometers used for measuring total body bone and soft tissue. Br J Radiol. 74:2001;166-176
22. Berneis K., Oehri M., Kraenzlin M., et al. Effects of IGF-1 combined with GH on glucocorticoid-induced changes of bone and connective tissue turnover in man. J Endocrinol. 162:1999;259-264
23. von Mach M.A., Brinkmann C., Hansen T., et al. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers. Exp Clin Endocrinol Diabetes. 110:2002;416-419
24. Livingston E.H. Obesity and its surgical management. Am J Surg. 184:2002;103-113
25. Prystowsky J.B. Surgical management of obesity. Semin Gastrointest Dis. 13:2002;133-142
26. Tothill P., Laskey M.A., Orphanidou C.I., et al. Anomalies in dual energy x-ray absorptiometry measurements of total-body bone mineral during weight change using lunar, hologic and norland instruments. Br J Radiology. 72:1999;661-669
27. Vestergaard P., Bǒrglum J., Heickendorff L., et al. Artifact in bone mineral measurements during a very low calorie diet. J Clin Densitometry. 3:2000;63-71
28. van Loan M.D., Johnson H.L., Barbieri T.F. Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr. 67:1998;734-738
29. Ferretti J.L., Cointry G.R., Capozza R.F., et al. Bone mass, bone strength, muscle-bone interactions, osteopenias and osteoporoses. Mech Ageing Dev. 124:2003;269-279
30. Blain H., Vuillemin A., Guillemin F., et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 87:2002;1030-1035
31. Bernstein C.N., Leslie W.D. The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol. 15:2003;857-864
32. Hannan M.T., Felson D.T., Dawson-Hughes B., et al. Risk factors for longitudinal bone loss in elderly men and women The Framingham Osteoporosis Study. J Bone Miner Res. 15:2000;710-720
33. Shaker J.L., Norton A.J., Woods M.F., et al. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int. 1:1991;177-181
34. Evans J.D., Scott M.H., Brown A.S., et al. Laparoscopic adjustable gastric banding for the treatment of morbid obesity. Am J Surg. 184:2002;97-102
35. Pontiroli A.E., Pizzocri P., Librenti M.C., et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications A three-year study. J Clin Endocrinol Metab. 87:2002;3555-3561
36. Belachew M., Belva P.H., Desaive C. Long-term results of laparoscopic adjustable gastric banding for the treatment of morbid obesity. Obes Surg. 12:2002;564-568
37. Murr M.M., Balsiger B.M., Kennedy F.P., et al. Malabsorptive procedures for severe obesity comparison of pancreaticobiliary bypass and very long limb Roux-en-Y gastric bypass. J Gastrointest Surg. 3:1999;607-612
38. Ott M.T., Fanti P., Malluche H.H., et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg. 2:1992;341-348
39. Buffington C., Walker B., Cowan G.S. Jr, et al. Vitamin D deficiency in the morbidly obese. Obes Surg. 3:1993;421-424
40. Avenell A., Richmond P.R., Lean M.E., et al. Bone loss associated with a high fibre weight reduction diet in postmenopausal women. Eur J Clin Nutr. 48:1994;561-566
41. Ricci T.A., Heymsfield S.B., Pierson R.N. Jr, et al. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr. 73:2001;347-352